Dietary intake of nuts and cardiovascular prognosis

Ochsner Journal

Volumn 9, Issue 1, 2009, Pages 32-36

  Good, David ^a   Lavie, Carl J ^b   Ventura, Hector O ^b  

^a Montgomery Cardiovascular Associates   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Cardiovascular disease; Diet; Fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID;

BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD INTAKE; HUMAN; HYPERTENSION; NUT; PROGNOSIS; REVIEW; WEIGHT GAIN;

EID: 65649138080     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Keys A, Mienotti A, Karvonen M J, et al. The diet and 15-year death rate In the seven countries study. Am J Epidemiol. 1986;24:903-915.
2. Sabate J. Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr. 1999;70:500S-503S.
3. Hu FB, Stampfer MJ, Manson JE, et al. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ. 1998;317:1341-1345.
4. Albert CM, Gaziano JM, Willet WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med. 2002; 162: 1382-1387.
5. Fraser GE, Lindsted KD, Beeson WL Effect of risk factor values on lifetime risk of and age at first coronary event. The Adventist Health Study. Am J Epidemiol. 1995; 142: 746-758.
6. Fraser GE, Sabate J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease.
7. The Adventist Health Study. Arch Intern Med. 1992;152: 1416-1424.
8. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. NEngl JMed. 1997; 336: 1117-1124.
9. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003; 290: 502-510. (Pubitemid 37430504)
10. Rajaram S, Burke K, Connell B, Myint T, Sabate J. A monounsaturated fatty acid-rich pecan-enriched diet favorably alters the serum lipid profile of healthy men and women. J Nutr. 2001; 131: 2275-2279. (Pubitemid 32851868)
11. Sabate J, Fraser GE, Burke K, Knutsen SF, Bennett H, Lindsted KD. Effects of walnuts on serum lipid levels and blood pressure in normal men. N Engl J Med. 1993; 328: 603-607. (Pubitemid 23065359)
12. Zambon D, Sabate J, Mũnoz S, et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women: a randomized crossover trial. Ann Intern Med. 2000; 132: 538-546. (Pubitemid 30171893)
13. Kocyigit A, Koylua AA, Keles H. Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis. 2006; 16: 202-209.
14. Alper CM, Mattes RD. Peanut consumption improves indices of cardiovascular disease risk in healthy adults. J Am Coll Nutr. 2003; 22:133-141.
15. Lavedrine F, Zmirou D, Ravel A, Balducci F, Alary J. Blood cholesterol and walnut consumption: a cross-sectional survey in France. Prev Med. 1999; 28: 333-339.
16. Berry EM, Eisenberg S, Haratz D, et al. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins-the
17. Jerusalem Nutrition Study: high MUFAs vs high PUFAs. Am J Clin Nutr. 1991; 53: 899-907.
18. St-Onge MP. Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? Am J Clin Nutr. 2005; 81: 7-15.
19. He K, Song Y, Belin RJ, Chen Y. Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr. 2006; 1: 351-355.
20. Beyer FR, Dickinson HO, Nicolson DJ, Ford GA, Mason J. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006; 3: CD004805.
21. Dickinson HO, Nicolson DJ, Campbell F, et al. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev. 2006; 3: CD004640.
22. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993; 328: 1450-1456.
23. Lonn E, Bosch J, Yusuf S, et al. HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005; 293: 1338-1347.
24. Riccioni G, Bucciarelli T, Mancini B, et al. Antioxidant vitamin supplementation in cardiovascular diseases. Ann Clin Lab Sci. 2007; 37: 89-95.
25. Anand RG, Alkadri M, Lavie CJ, Milani RV. The role of fish oil in arrhythmia prevention. J Cardiopul Rehabil Prev. 2008; 28: 92-98.
26. Artham SA, Lavie CJ, Milani RV, Anand RG, O'Keefe JH, Ventura HO. Fish oil in primary and secondary cardiovascular prevention. The Ochsner Journal. 2008; 8: 49-60.
27. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008; 83: 324-332.
28. Holub BJ. Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis. CMAJ. 1988; 139: 377-381.
29. Wang C, Harris WS, Chung M, et al. n-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondaryprevention studies: a systematic review. Am J Clin Nutr. 2006; 84: 5-17.
30. Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005; 293: 2884-2891.
31. Marangoni F, Colombo C, Martiello A, Poli A, Paoletti R, Galli C. Levels of the n-3 fatty acid eicosapentaenoic acid in addition to those of alpha linolenic acid are significantly raised in blood lipids by the intake of four walnuts a day in humans. Nutr Metab Cardiovasc Dis. 2007; 17: 457-461.
32. De Lorgeril M, Salen P. The Mediterranean-style diet for the prevention of cardiovascular diseases. Public Health Nutr. 2006; 9: 118-123.
33. Galli C, Marangoni F. N-3 fatty acids in the Mediterranean diet. Prostaglandins Leukot Essent Fatty Acids. 2006; 75: 129-133.
34. Simon JA, Fong J, Bernert JT Jr, Browner WS. Serum fatty acids and the risk of stroke. Stroke. 1995; 26: 778-782.
35. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr. 2004; 134: 2991-2997.
36. Rallidis LS, Paschos G, Llakos GK, Velissarldou AH, Anastasiadls G, Zampelas A. Dietary alpha-llnolenic acid decreases C-reactlve protein, serum amyloid A and lnterleukln-6 in dyslipldaemic patients. Atherosclerosis. 2003; 167: 237-242.
37. Paschos GK, Ylannakouris N, Rallidis LS, et al. Apolipoprotein E genotype in dysllpidemic patients and response of blood lipids and inflammatory markers to alpha-linolenlc acid. Angiology. 2005;56: 49-60.
38. Harris WS, Mozaffarian D, Rlmm E, et al. Omega-6 Fatty Acids and Risk for Cardiovascular Disease. A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009 Jan 26 [Epub ahead of print].
39. Lavie CJ, Milan! RV. Editorial Comment. Obesity and cardiovascular disease: The Hippocrates paradox? J Am Coll Cardiol. 2003; 42:6 77-679.
40. Lavle CJ, Mllanl RV. Exercise training in special populations: Obesity. In: Wenger NC, Smith K, Frolicher E, Composs P, eds. Cardiac Rehabilitation: A Guide for the 21st Century. New York: Marcel Dekker, Inc., 1999:151-154.
41. Lavie CJ, Milani RV. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life In obese coronary patients. Am J Cardiol. 1997; 79: 397-401.
42. Lavie CJ, Milani RV, Messerli FH. From obesity, hypertension, and left ventricular hypertrophy to congestive heart failure. The Ochsner Journal. 2000;2 (suppl.1) : S8-S14.
43. Bes-Rastrollo M, Sabate J, Gomez-Gracia E, Alonso A, Martinez JA, Martinez-Gonzalez MA. Nut consumption and weight gain in a Mediterranean cohort: the SUN study. Obesity (Silver Spring). 2007; 15: 107-116.
44. Coelho SB, de Sales RL, Iyer SS, et al. Effects of peanut oil load on energy expenditure, body composition, lipid profile, and appetite in lean and overweight adults. Nutrition. 2006; 22: 585-592.
45. Adams AM. Pedagogical underpinnings of computer-based learning. J Adv Nurs. 2004;6:5-12. (Pubitemid 38491021)